Drug Profile
Research programme: nanotechnology-based therapeutics - Qualiber
Alternative Names: Nano GTP; Nano VP16; NanoSi CD36Latest Information Update: 28 Oct 2020
Price :
$50
*
At a glance
- Originator Qualiber
- Class Deoxyribonucleosides; Pyrimidine nucleosides; Small interfering RNA; Small molecules
- Mechanism of Action DNA synthesis inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Hepatitis B; Lung cancer; Lymphoma; Pancreatic cancer
Most Recent Events
- 28 Oct 2020 No recent reports of development identified for research development in Hepatitis-B in USA
- 28 Oct 2020 No recent reports of development identified for research development in Lung-cancer in USA
- 28 Oct 2020 No recent reports of development identified for research development in Lymphoma in USA